Arecor has a proprietary and patented technology platform for improving the stability of a range of therapeutic proteins including vaccines, monoclonal antibodies, peptides, blood factors and fusion proteins
Dr Sarah HowellChief Operations Officer
Domainex is a drug discovery company with a reputation for speed and innovation built on an exceptional track record of drug candidate delivery. It has a world class discovery team with an unrivalled track record and three client drug candidates
Dr Eddy LittlerChief Executive Officer
Dr Keith PowellChairman
Haemostatix has developed a new class of peptide-based haemostat for the treatment of bleeding. The technology is based on a peptide that binds to the blood protein fibrinogen, inducing the rapid and targeted formation of clots.
Dr Ben NicholsChief Executive Officer
Kymab is a biopharmaceutical company engaged in the discovery and development of human monoclonal antibody therapeutics.
Dr Tom ShepherdChief Business Officer
PolyTherics is a biotechnology company that offers a comprehensive range of site-specific conjugation technologies and polymer-based technologies which are being applied to the development and enhancement of biologicals and other therapeutic entities.
Dr John BurtChief Executive Officer
Dr Jennifer FilbeyUS consultant
ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.